<DOC>
	<DOCNO>NCT00830466</DOCNO>
	<brief_summary>The researcher want collect data safety efficacy combine pulsed dye laser rapamycin improve fading/blanching port wine stain birthmark compare pulsed dye laser alone , current standard care . This single center pilot feasibility study target enrollment 40 port wine stain subject Beckman Laser Institute Medical Clinic , University California , Irvine .</brief_summary>
	<brief_title>A Randomized Trial Study Combined Pulsed Dye Laser Rapamycin Treatment Port Wine Stain Birthmarks .</brief_title>
	<detailed_description>The study offer two different approach treatment port wine stain birthmark . Study Group Number 1 : Port wine stain treat pulsed dye laser alone , current standard care : 20 subject . Study Group Number 2 : Port wine stain treat combined pulsed dye laser rapamycin : 20 subject . The researcher want collect data safety efficacy combine pulsed dye laser rapamycin improve fading/blanching port wine stain birthmark compare pulsed dye laser alone , current standard care . Twenty subject entire port wine stain birthmark treat pulsed dye laser alone . Twenty subject entire port wine stain birthmark treat combined pulsed dye laser rapamycin , drug prevents formation blood vessel skin . Safety evaluate search local effect injury skin systemic effect abnormal blood and/or urine study . Efficacy determine objectively measure compare port wine stain fading/blanching response two study group .</detailed_description>
	<mesh_term>Port-Wine Stain</mesh_term>
	<mesh_term>Hemangioma , Capillary</mesh_term>
	<mesh_term>Vascular Malformations</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Port wine stain suitable comparison test . Age &gt; 13 year age old ; minor accompany room parent guardians laser treatment . Apparent good health document medical history . Ability understand carry subject instruction . Women childbearing potential must negative urinary pregnancy test prior start rapamycin . Women child bear potential must agree use medically acceptable method contraception throughout study 3 month follow discontinuation rapamycin . Inability understand carry instruction . Pregnancy . Abnormal blood urine test History cancer . History high cholesterol , lipids liver disease . Allergy macrolide drug ( e.g. , erythromycin ) . Any therapy within previous two month propose port wine stain treatment site . Current participation investigational drug evaluation . Concurrent use know photosensitize drug . Concurrent use immunosuppressive drug steroid . Concurrent use follow medication : antifungal , antiepileptic , protease inhibitor , cimetidine , cisapride , clarithromycin , dannzol , diltiazem , erythromycin , metoclopramide , rifabutin , rifampin , rifapetine , troleandomycin , verapamil .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>port wine stain</keyword>
</DOC>